SETD2 and neoplasm: In addition, mutations in the tumour suppressors BAP1, PBRM1 and SETD2, which co-localise with VHL on chromosome 3p and are frequently disrupted in ccRCC, suppress ISGF3-mediated ISG expression87–89.